The VYRITAK brand, founded in 2010 (United States), from 18 sister brands and 2214 competing brands. VYRITAK is a brand of Vertex Pharma, listed on the stock exchange of New York. VYRITAK belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Vertex Pharma
(VYRITAK)
over 5 years*
USD 945.78